As part of the live broadcast series by AtlanticLive titled “The Next Drugs: An Atlantic Policy Update on Biosimilar”, Foley partner Courtenay Brinckerhoff will join the panel of speakers to address the current Supreme Court case on the patent dance, intellectual property and exclusivity issues, and the way forward.
The speakers include:
- Courtenay Brinckerhoff, Partner, Foley & Lardner LLP
- Phil Nickson, Associate General Counsel for IP, Momenta Pharmaceuticals
- Representative Peter Welch (D-VT)
- Steve Clemons, Washington Editor at Large, The Atlantic
- Olga Khazan, Staff Writer, The Atlantic
For more information and to register, please visit AtlanticLive’s website.
People
Related Insights
August 14, 2025
Foley Ignite
Will the Late Summer M&A Rebound Continue into Fall?
The lazy days of summer seem to be behind us as merger and acquisition (M&A) activity is getting a jump start. A recent article in the…
August 14, 2025
Manufacturing Industry Advisor
Tariffs and Your Contracts: Why do delivery terms matter?
In light of a trade landscape rife with tariffs, companies are examining their commercial contracts to judge the exposure to increased costs of production. One area of a supply contract that cannot be overlooked when determining this type of exposure is the delivery terms for the product sale. This is because the delivery terms of a contract may identify the party responsible for payment of tariffs.
August 14, 2025
Foley Viewpoints
SEC Intensifies Scrutiny of Chief Compliance Officers
Two recent SEC enforcement actions serve as a sharp reminder that Chief Compliance Officers (CCOs) can face personal liability for what…